Abstract
Cardiovascular diseases are the leading cause of morbidity, disability and death worldwide. The importance of the burden of cardiovascular diseases varies geographically and evolves simultaneously to the change in societies. The changes in patterns of diseases and their interaction with socio-economic transformation have been termed “epidemiological transition”. The present paper presents public health perspective of the evolution of cardiovascular risk profile associated to high dietary salt consumption in both developed and developing countries. The model of primary prevention of hypertension through non-pharmacological methods is presented as an effective population approach to reduce the risk of cardiovascular morbidity and mortality. In particular, the results of randomized controlled trials unequivocally show the efficacy of moderate sodium restriction in lowering blood pressure in both normotensive and hypertensive individuals. The effect of this measure is larger in hypertensives, elderly and “low-renin” black populations. Finally, the appropriateness and efficacy of a population approach to reduce salt consumption in developed as well in developing countries are discussed.
Keywords: epidemiological transition, public health, cardiovascular disease, diet, blood pressure, hypertension, sodium
Related Journals
Related Articles
-
Aliskiren: A New Drug for an Old Problem
Cardiovascular & Hematological Agents in Medicinal Chemistry Prostacyclin, Atherothrombosis, and Cardiovascular Disease
Current Medicinal Chemistry Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine
Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics) The Crosstalk Between Insulin and Renin-Angiotensin-Aldosterone Signaling Systems and its Effect on Glucose Metabolism and Diabetes Prevention
Current Vascular Pharmacology Hereditary Haemorrhagic Telangiectasia (HHT): Genetic and Molecular Aspects
Current Pharmaceutical Design 5-HT and NA Reuptake Inhibitors and Appetite Regulation: The Role of the Central 5-HT Network
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization) Renal Artery Stenosis: Current Perspectives on Imaging and Endovascular Management
Current Hypertension Reviews Treatment of Hypertension to Prevent Atrial Fibrillation
Current Pharmaceutical Design Non-dipping Status in Arterial Hypertension: An Overview
Current Vascular Pharmacology Chronic Thromboembolic Pulmonary Hypertension-Therapeutic Options
Current Respiratory Medicine Reviews Serum Uric Acid is Independently Associated with Diastolic Dysfunction in Apparently Healthy Subjects with Essential Hypertension
Current Vascular Pharmacology Overcoming Barriers to Evidence-Based Diabetes Care
Current Diabetes Reviews Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome
Current Medicinal Chemistry Ventilatory Support in Persistent Pulmonary Hypertension of the Newborn
Current Respiratory Medicine Reviews Telmisartan, its Potential Therapeutic Implications in Cardiometabolic Disorders
Recent Patents on Cardiovascular Drug Discovery (Discontinued) Adiponectin: A Key Player in Obesity Related Disorders
Current Pharmaceutical Design Recent Progress of Medicinal Chemistry Research on Peroxisome Proliferator-Activated Receptor (PPAR) Ligands for the Treatment of Metabolic Syndrome
Current Bioactive Compounds Calcium Metabolism and Oxidative Stress in Bone Fractures: Role of Antioxidants
Current Drug Metabolism Pharmacotherapy for the Metabolic Syndrome
Current Vascular Pharmacology Prostacyclin Synthase Gene: Genetic Polymorphisms and Prevention of Some Cardiovascular Diseases
Current Medicinal Chemistry - Cardiovascular & Hematological Agents